Literature DB >> 10972823

Analysis of mutants of tetanus toxin Hc fragment: ganglioside binding, cell binding and retrograde axonal transport properties.

K Sinha1, M Box, G Lalli, G Schiavo, H Schneider, M Groves, G Siligardi, N Fairweather.   

Abstract

Tetanus toxin binds neuronal tissue prior to internalization and trafficking to the central nervous system. Binding of the carboxy-terminal 50 kDa HC fragment of tetanus toxin to polysialogangliosides is important for this initial cell binding step. Using the three-dimensional structure of HC, mutants were designed to investigate the role of individual residues in ganglioside binding. Mutant proteins were tested for binding to GT1b gangliosides, to primary motoneurons and for their ability to undergo retrograde transport in mice. Two classes of mutant were obtained: (i) those containing deletions in loop regions within the C-terminal beta-trefoil domain which showed greatly reduced ganglioside and cell binding and did not undergo retrograde transport and (ii) those that showed reduced ganglioside binding, but retained primary neuronal cell binding and retrograde transport. The second class included point mutants of Histidine-1293, previously implicated in GT1b binding. Our deletion analysis is entirely consistent with recent structural studies which have identified sugar-binding sites in the immediate vicinity of the residues identified by mutagenesis. These results demonstrate that ganglioside binding can be severely impaired without abolishing cell binding and intracellular trafficking of tetanus toxin.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10972823     DOI: 10.1046/j.1365-2958.2000.02091.x

Source DB:  PubMed          Journal:  Mol Microbiol        ISSN: 0950-382X            Impact factor:   3.501


  19 in total

1.  Neuronal activity-dependent membrane traffic at the neuromuscular junction.

Authors:  Francisco Javier Miana-Mena; Sylvie Roux; Jean-Claude Benichou; Rosario Osta; Philippe Brûlet
Journal:  Proc Natl Acad Sci U S A       Date:  2002-03-05       Impact factor: 11.205

2.  A conformational change of C fragment of tetanus neurotoxin reduces its ganglioside-binding activity but does not destroy its immunogenicity.

Authors:  Rui Yu; Shaoqiong Yi; Changming Yu; Ting Fang; Shuling Liu; Ting Yu; Xiaohong Song; Ling Fu; Lihua Hou; Wei Chen
Journal:  Clin Vaccine Immunol       Date:  2011-08-03

3.  Reduction of the ganglioside binding activity of the tetanus toxin HC fragment destroys immunogenicity: implications for development of novel tetanus vaccines.

Authors:  Omar Qazi; Dorothea Sesardic; Robert Tierney; Zahra Söderbäck; Dennis Crane; Barbara Bolgiano; Neil Fairweather
Journal:  Infect Immun       Date:  2006-08       Impact factor: 3.441

4.  Gangliosides as high affinity receptors for tetanus neurotoxin.

Authors:  Chen Chen; Zhuji Fu; Jung-Ja P Kim; Joseph T Barbieri; Michael R Baldwin
Journal:  J Biol Chem       Date:  2009-07-14       Impact factor: 5.157

5.  Binding of Clostridium difficile surface layer proteins to gastrointestinal tissues.

Authors:  Emanuela Calabi; Franco Calabi; Alan D Phillips; Neil F Fairweather
Journal:  Infect Immun       Date:  2002-10       Impact factor: 3.441

6.  Characterisation of a panel of anti-tetanus toxin single-chain Fvs reveals cooperative binding.

Authors:  Nathan Scott; Omar Qazi; Michael J Wright; Neil F Fairweather; Mahendra P Deonarain
Journal:  Mol Immunol       Date:  2010-04-22       Impact factor: 4.407

7.  Fragment C of tetanus toxin, more than a carrier. Novel perspectives in non-viral ALS gene therapy.

Authors:  María Moreno-Igoa; Ana Cristina Calvo; Clara Penas; Raquel Manzano; Sara Oliván; María Jesús Muñoz; Renzo Mancuso; Pilar Zaragoza; José Aguilera; Xavier Navarro; Rosario Osta Pinzolas
Journal:  J Mol Med (Berl)       Date:  2010-03       Impact factor: 4.599

8.  Tetanus toxin C fragment-conjugated nanoparticles for targeted drug delivery to neurons.

Authors:  Seth A Townsend; Gilad D Evrony; Frank X Gu; Martin P Schulz; Robert H Brown; Robert Langer
Journal:  Biomaterials       Date:  2007-09-14       Impact factor: 12.479

Review 9.  Receptor and substrate interactions of clostridial neurotoxins.

Authors:  Axel T Brunger; Andreas Rummel
Journal:  Toxicon       Date:  2009-03-04       Impact factor: 3.033

10.  A gold nanoparticle-linked glycoconjugate vaccine against Burkholderia mallei.

Authors:  Anthony E Gregory; Barbara M Judy; Omar Qazi; Carla A Blumentritt; Katherine A Brown; Andrew M Shaw; Alfredo G Torres; Richard W Titball
Journal:  Nanomedicine       Date:  2014-09-03       Impact factor: 5.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.